Vinsamlegast notið þetta auðkenni þegar þið vitnið til verksins eða tengið í það: http://hdl.handle.net/1946/40284
This case study provides the perspective of a fast-growing IT company in the context of the COVID-19 pandemic. Many businesses around the world struggled to survive during the pandemic, while Controlant, an Icelandic end-to-end cold supply chain monitoring company, can be argued to have disrupted its industry. Controlant is a company that is primarily involved in the monitoring of COVID-19 vaccine shipments for Pfizer and other vaccine manufacturers. In this thesis, I provide the story of Controlant, from its early stages to the present. Controlant’s path is then discussed through the lens of classical and modern theories about disruption and data driven innovation. The aim is to provide evidence and analysis of Controlant’s disruption. With its technologies, Controlant was able to collect and create big data from the pharmaceutical supply chain. The research examines how Controlant, in less than fourteen months, was able to face its challenges to reach a level of scalability. The company's internal databases were previously designed to accommodate a smaller amount of data compared to what the firm is facing nowadays. This thesis focuses its research in analyzing Controlant disruption through its hardware and services and maintaining the leading position of the market with data-driven innovation processes. With its solutions, Controlant reached an efficiency level of 99.99% in delivering Pfizer vaccines around the world. The global pandemic played the role of a catalyst in shifting balances in the pharmaceutical supply chain industry. Meanwhile, we can speculate that the disruption would have occurred even without the COVID-19 crisis.
|Disrupting Cold Supply Chain Monitoring Systems Industry with Data - The Controlant Case Study.pdf
Athugsemd: To read this Master Thesis is mandatory to sign an NDA with Controlant.